Measles, Mumps, and Rubella vaccination in children with egg allergy

Detalhes bibliográficos
Autor(a) principal: Cunha, Leonor
Data de Publicação: 2022
Outros Autores: Almeida, Diana, Rodrigues dos Santos, Filipa, Falcão, Helena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.25753/BirthGrowthMJ.v31.i1.23897
Resumo: Introduction: Egg allergy is one of the most common food allergies in childhood. Administration of the measles, mumps, and rubella (MMR) vaccine is recommended in pediatric age. Despite the presence of traces of egg protein in its composition, the literature recommends MMR vaccine administration regardless of the patient’s past egg allergy history, identifying cases in which the administration should occur in hospital setting. Purpose: To characterize the pediatric population referred to the Allergy and Clinical Immunology Department of Centro Hospitalar Universitário do Porto for MMR vaccine administration and investigate vaccination safety in children with egg allergy or sensitization. Methods: This was a retrospective observational study of clinical records of children with confirmed or suspected egg allergy referred to the Allergy and Clinical Immunology Department for administration of the MMR vaccine between January 1, 2013 and December 31, 2019. Results: Among 60 children studied, 90% presented symptoms upon egg intake, with cutaneous reactions being the most prevalent (67%) and four reported cases of anaphylaxis. Allergy to cow’s milk protein (55%), followed by allergy to other foods (45%) were the most frequent personal histories of allergic diseases. Asthma was identified in 10% of patients and was controlled in all cases. Among children referred for vaccination booster dose, one had had a reaction to the previous MMR vaccine dose. Three children developed late local skin reactions, and one had a late systemic reaction after vaccination. All children had negative oral food challenge. Conclusion: MMR vaccine administration is safe and recommended in pediatric age, regardless of egg allergy history. However, immunization should be performed in hospital setting in children with a history of anaphylaxis due to egg allergy, previous anaphylactic reaction to MMR vaccine or one of its constituents, uncontrolled asthma with documented egg allergy, and uncontrolled asthma with allergy to a previous MMR vaccine dose.
id RCAP_1f02c7bf73cd79e043e4a30158e6a5be
oai_identifier_str oai:ojs.revistas.rcaap.pt:article/23897
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Measles, Mumps, and Rubella vaccination in children with egg allergyVacinação Anti-Sarampo, Parotidite e Rubéola na criança com alergia ao ovoOriginal ArticlesIntroduction: Egg allergy is one of the most common food allergies in childhood. Administration of the measles, mumps, and rubella (MMR) vaccine is recommended in pediatric age. Despite the presence of traces of egg protein in its composition, the literature recommends MMR vaccine administration regardless of the patient’s past egg allergy history, identifying cases in which the administration should occur in hospital setting. Purpose: To characterize the pediatric population referred to the Allergy and Clinical Immunology Department of Centro Hospitalar Universitário do Porto for MMR vaccine administration and investigate vaccination safety in children with egg allergy or sensitization. Methods: This was a retrospective observational study of clinical records of children with confirmed or suspected egg allergy referred to the Allergy and Clinical Immunology Department for administration of the MMR vaccine between January 1, 2013 and December 31, 2019. Results: Among 60 children studied, 90% presented symptoms upon egg intake, with cutaneous reactions being the most prevalent (67%) and four reported cases of anaphylaxis. Allergy to cow’s milk protein (55%), followed by allergy to other foods (45%) were the most frequent personal histories of allergic diseases. Asthma was identified in 10% of patients and was controlled in all cases. Among children referred for vaccination booster dose, one had had a reaction to the previous MMR vaccine dose. Three children developed late local skin reactions, and one had a late systemic reaction after vaccination. All children had negative oral food challenge. Conclusion: MMR vaccine administration is safe and recommended in pediatric age, regardless of egg allergy history. However, immunization should be performed in hospital setting in children with a history of anaphylaxis due to egg allergy, previous anaphylactic reaction to MMR vaccine or one of its constituents, uncontrolled asthma with documented egg allergy, and uncontrolled asthma with allergy to a previous MMR vaccine dose.Introdução: A alergia ao ovo representa uma das alergias alimentares mais frequentes na infância. A administração da vacina anti-sarampo, parotidite e rubéola (VASPR) é recomendada em idade pediátrica. Apesar da presença de vestígios de ovalbumina na composição da vacina, a literatura recomenda a sua administração independentemente da história de alergia, advertindo para os casos em que a mesma deve ocorrer em ambiente hospitalar. Objetivo: Caracterizar a população pediátrica referenciada para a consulta de Imunoalergologia do Centro Hospitalar Universitário do Porto para administração da VASPR, bem como a segurança da mesma em crianças com alergia ou sensibilização ao ovo. Métodos: Estudo observacional retrospetivo dos processos clínicos de crianças referenciadas para a consulta de Imunoalergologia para administração da VASPR com alergia suspeita ou confirmado a ovo entre 1 de janeiro de 2013 e 31 de dezembro de 2019. Resultados: Das 60 crianças estudadas, 90% apresentaram sintomas mediante ingestão de ovo, predominantemente cutâneos (67%) mas também anafilaxia em quatro casos. Alergia à proteína do leite de vaca (55%), seguida da alergia a outros alimentos (45%) foram os antecedentes pessoais de doença alérgica mais frequentes. Foi identificada asma em 10% dos casos, encontrando-se controlada em todos. Das crianças referenciadas para administração de reforço vacinal, uma tinha apresentado reação à dose prévia da VASPR. Três crianças desenvolveram reação cutânea local tardia e uma desenvolveu reação sistémica tardia após administração da VASPR. Todas tiveram prova de provocação oral negativa. Conclusão: A administração da VASPR é segura e a sua recomendação mantém-se mesmo em crianças com alergia ao ovo. Contudo, a inoculação deve ser realizada em ambiente hospitalar em crianças com reação anafilática ao ovo, reação anafilática a uma dose prévia da vacina ou seus componentes, asma não controlada e alergia ao ovo, ou asma não controlada e alergia a uma dose prévia da vacina.Centro Hospitalar Universitário do Porto2022-04-04T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.25753/BirthGrowthMJ.v31.i1.23897eng2183-9417Cunha, LeonorAlmeida, DianaRodrigues dos Santos, FilipaFalcão, Helenainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T14:55:43Zoai:ojs.revistas.rcaap.pt:article/23897Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:56:33.356123Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Measles, Mumps, and Rubella vaccination in children with egg allergy
Vacinação Anti-Sarampo, Parotidite e Rubéola na criança com alergia ao ovo
title Measles, Mumps, and Rubella vaccination in children with egg allergy
spellingShingle Measles, Mumps, and Rubella vaccination in children with egg allergy
Cunha, Leonor
Original Articles
title_short Measles, Mumps, and Rubella vaccination in children with egg allergy
title_full Measles, Mumps, and Rubella vaccination in children with egg allergy
title_fullStr Measles, Mumps, and Rubella vaccination in children with egg allergy
title_full_unstemmed Measles, Mumps, and Rubella vaccination in children with egg allergy
title_sort Measles, Mumps, and Rubella vaccination in children with egg allergy
author Cunha, Leonor
author_facet Cunha, Leonor
Almeida, Diana
Rodrigues dos Santos, Filipa
Falcão, Helena
author_role author
author2 Almeida, Diana
Rodrigues dos Santos, Filipa
Falcão, Helena
author2_role author
author
author
dc.contributor.author.fl_str_mv Cunha, Leonor
Almeida, Diana
Rodrigues dos Santos, Filipa
Falcão, Helena
dc.subject.por.fl_str_mv Original Articles
topic Original Articles
description Introduction: Egg allergy is one of the most common food allergies in childhood. Administration of the measles, mumps, and rubella (MMR) vaccine is recommended in pediatric age. Despite the presence of traces of egg protein in its composition, the literature recommends MMR vaccine administration regardless of the patient’s past egg allergy history, identifying cases in which the administration should occur in hospital setting. Purpose: To characterize the pediatric population referred to the Allergy and Clinical Immunology Department of Centro Hospitalar Universitário do Porto for MMR vaccine administration and investigate vaccination safety in children with egg allergy or sensitization. Methods: This was a retrospective observational study of clinical records of children with confirmed or suspected egg allergy referred to the Allergy and Clinical Immunology Department for administration of the MMR vaccine between January 1, 2013 and December 31, 2019. Results: Among 60 children studied, 90% presented symptoms upon egg intake, with cutaneous reactions being the most prevalent (67%) and four reported cases of anaphylaxis. Allergy to cow’s milk protein (55%), followed by allergy to other foods (45%) were the most frequent personal histories of allergic diseases. Asthma was identified in 10% of patients and was controlled in all cases. Among children referred for vaccination booster dose, one had had a reaction to the previous MMR vaccine dose. Three children developed late local skin reactions, and one had a late systemic reaction after vaccination. All children had negative oral food challenge. Conclusion: MMR vaccine administration is safe and recommended in pediatric age, regardless of egg allergy history. However, immunization should be performed in hospital setting in children with a history of anaphylaxis due to egg allergy, previous anaphylactic reaction to MMR vaccine or one of its constituents, uncontrolled asthma with documented egg allergy, and uncontrolled asthma with allergy to a previous MMR vaccine dose.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-04T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.25753/BirthGrowthMJ.v31.i1.23897
url https://doi.org/10.25753/BirthGrowthMJ.v31.i1.23897
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2183-9417
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Centro Hospitalar Universitário do Porto
publisher.none.fl_str_mv Centro Hospitalar Universitário do Porto
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130434041282560